Dr. Ronald A Popper, M.D. F.C.C.P. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 317 S Moorpark Rd, Thousand Oaks, CA 91361 Phone: 805-557-9930 Fax: 805-557-9940 |
Dr. Paul Ronald Block, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 227 W Janss Rd, Ste 305, Thousand Oaks, CA 91360 Phone: 805-449-4181 Fax: 805-494-9152 |
Dr. Miguel Abelino Gonzalez, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 303 S Moorpark Rd, Thousand Oaks, CA 91361 Phone: 805-497-7508 Fax: 805-371-4200 |
Dr. Lawrence Arthur Baker, M.D. Internal Medicine - Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 227 W Janss Rd, Ste 250, Thousand Oaks, CA 91360 Phone: 805-497-7508 Fax: 805-495-6834 |
Andres Enrique Giron, M.D. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 555 Marin St, Suite 110, Thousand Oaks, CA 91360 Phone: 805-496-0440 Fax: 805-496-9808 |
News Archive
Aerocrine AB today announced the launch of a strategic alliance with Meditab Software Inc. at the American Association of Allergy, Asthma and Immunology annual meeting in San Francisco on March 19-21.
Hastings Center Scholar Erik Parens, PhD, will speak about behavioral genetics to the Presidential Commission for the Study of Bioethical Issues on Monday, February 28. The meeting kicks off the Commission's examination of the ethical and policy issues raised by genetics and neuroscience. Topics will include the use of genetics, neuroscience, and neuroimaging for testing, research, diagnosis, risk identification, and health promotion. Parens was invited to discuss what he considers the most pressing ethical and social issues that behavioral genetics research raises.
A team of researchers at The University of Texas Health Science Center at Houston School of Public Health has received a $3.1 million grant from the National Institutes of Health to study how gut bacteria play a role in the development of diabetes among residents of Starr County, Texas.
Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas HSV 1 and 2 Test for the direct detection and differentiation of HSV-1 and HSV-2 DNA in anogenital specimens from symptomatic patients. With dual target detection and automation, the cobas HSV 1 and 2 Test provides laboratories with the capability to report up to 94 results in significantly less time than traditional methods and provides a simplified workflow for sample handling in the laboratory.
Women with a history of severe cervical intraepithelial neoplasia, a precancerous condition of the cervix that arises from infection with the human papillomavirus (HPV), had a long-term increased risk of developing anal, vulvar, and vaginal cancer.
› Verified 4 days ago